Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06979609Phase 2/3Recruiting
Secondary Prevention of Clostridioides Difficile Using Vancomycin
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
PrincipalinvestigatorStart date: 2025-11-01

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

McGill University Health Centre/Research Institute of the McGill University Health Centre

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Todd C. Lee, MD MPH

McGill University Health Centre/Research Institute of the McGill University Health Centre

Moderately Similar
2 trials

Shared therapeutic areas:

Clostridium difficile InfectionsClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborated on 1 trial
Similarity Score34%

Evangelos J Giamarellos-Bourboulis, MD, Phd

Hellenic Sepsis Study Group

Related
3 trials

Shared therapeutic areas:

Clostridium difficile InfectionsClostridioides Difficile Infection Recurrence
Similarity Score20%

Darrell Pardi, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Clostridium difficile InfectionsClostridioides Difficile Infection Recurrence
Similarity Score20%

Patrice Allibert

Meridian Bioscience, Inc.

Related
3 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score10%

Judit Szabo, M.D., Ph.D.

University of Debrecen

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score10%

Eva Rakoczi, M.D.

Kenezy Gyula Korhaz es Rendelointezet

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score10%

Gianluca Ianiro

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Related
3 trials

Shared therapeutic areas:

Clostridioides Difficile Infection Recurrence
Similarity Score10%

Istvan Varkonyi, M.D.

Kenezy Gyula Korhaz es Rendelointezet

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score10%

Tibor Pap, M.D.

Miskolci Semmelweis Korhaz es Egyetemi Oktatokorhaz

Related
1 trials

Shared therapeutic areas:

Clostridium difficile Infections
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06979609Phase 2/3PrincipalInvestigator

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
Recruiting

All 1 trials loaded